The HAS-BLED score identifies patients with acute venous thromboembolism at high risk of major bleeding complications during the first six months of anticoagulant treatment

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Kooiman, Judith ^a   Van Hagen, Nadja ^a   Del Sol, Antonio Iglesias ^b   Planken, Erwin V ^c   Lip, Gregory Y H ^d   Van Der Meer, Felix J M ^a   Cannegieter, Suzanne C ^a   Klok, Frederikus A ^a   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

^c Diaconessenhuis ^*  (Netherlands)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ASSESSMENT OF HUMANS; ATRIAL FIBRILLATION; BLEEDING; BLEEDING TENDENCY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HAS BLED SCORE; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUSCLE BLEEDING; PATIENT IDENTIFICATION; PREDICTIVE VALUE; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; COMPLICATION; HEMORRHAGE; INCIDENCE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; VEIN THROMBOSIS;

ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84929378311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122520     Document Type: Article

References (38)

1. Oger E (2000) Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 83: 657-660. 00050657 [pii]. PMID: 10823257
2. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al (2012) Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: e419S-e494S. 141/2-suppl/e419S [pii];doi: 10.1378/chest.11-2301 PMID: 22315268
3. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, et al (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340: 901-907. doi: 10.1056/NEJM199903253401201 PMID: 10089183
4. Linkins LA, Choi PT, Douketis JD (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 139: 893-900. 139/11/893 [pii]. PMID: 14644891
5. Schulman S, Beyth RJ, Kearon C, Levine MN (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 257S-298S. 133/6-suppl/257S [pii];doi: 10.1378/chest.08-0674 PMID: 18574268
6. Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, et al (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 336: 393-398. doi: 10.1056/NEJM199702063360601 PMID: 9010144
7. Nieto JA, Camara T, Gonzalez-Higueras E, Ruiz-Gimenez N, Guijarro R, Marchena PJ, et al(2008) Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 100: 789-796. 08110789 [pii]. PMID: 18989522
8. White RH, Beyth RJ, Zhou H, Romano PS (1999) Major bleeding after hospitalization for deep-venous thrombosis. Am J Med 107: 414-424. S0002-9343(99)00267-3 [pii]. PMID: 10569295
9. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al (2011) A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 58: 395-401. S0735-1097(11)01571-3 [pii];doi: 10.1016/j.jacc.2011.03.031 PMID: 21757117
10. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al (2006) Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 151: 713-719. S0002-8703(05)00436-9 [pii];doi: 10.1016/j.ahj.2005.04.017 PMID: 16504638
11. Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF (2006) Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 130: 1390-1396. 130/5/1390 [pii];doi: 10.1378/chest.130.5.1390 PMID: 17099015
12. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138: 1093-1100. chest.10-0134 [pii];doi: 10.1378/chest.10-0134 PMID: 20299623
13. Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY (2013) Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients. J Am Coll Cardiol 61: 386-387. S0735-1097(12)05300-4 [pii];doi: 10.1016/j.jacc.2012.10.010 PMID: 23246385
14. Lip GY, Lin HJ, Hsu HC, Su TC, Chen MF, Lee YT, et al (2013) Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study. Int J Cardiol. S0167-5273 (12)01705-6 [pii];doi: 10.1016/j.ijcard.2012.12.076
15. Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY (2012) Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol 60: 861-867. S0735-1097(12)02368-6 [pii];doi: 10.1016/j.jacc.2012.06.019 PMID: 22858389
16. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172: 1041-1046. 200506-862OC [pii];doi: 10.1164/rccm.200506-862OC PMID: 16020800
17. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243-250. doi: 10.1056/NEJM199701233360402 PMID: 8995086
18. Scherz N, Mean M, Limacher A, Righini M, Jaeger K, Beer HJ, et al (2013) Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism. J Thromb Haemost 11: 435-443. doi: 10.1111/jth.12111 PMID: 23279158
19. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69: 236-239. PMID: 8470047
20. Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3: 692-694. JTH1204 [pii];doi: 10.1111/j.1538-7836.2005.01204.x PMID: 15842354
21. Kuijer PM, Hutten BA, Prins MH, Buller HR (1999) Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med 159: 457-460. PMID: 10074953
22. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, et al (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349: 631-639. doi: 10.1056/NEJMoa035422;349/7/631 [pii]. PMID: 12917299
23. Ruiz-Gimenez N, Suarez C, Gonzalez R, Nieto JA, Todoli JA, Samperiz AL, et al (2008) Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 100: 26-31. 08070026 [pii];doi: 10.1160/TH08-03-0193 PMID: 18612534
24. Beyth RJ, Quinn LM, Landefeld CS (1998) Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105: 91-99. S0002934398001983 [pii]. PMID: 9727814
25. Camm AJ, Lip GY, De CR, Savelieva I, Atar D, Hohnloser SH, et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 14: 1385-1413. eus305 [pii];doi: 10.1093/europace/eus305 PMID: 22923145
26. Ruiz-Gimenez N, Suarez C, Gonzalez R, Nieto JA, Todoli JA, Samperiz AL, et al (2008) Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thrombosis and Haemostasis 100: 26-31. doi: 10.1160/TH08-03-0193 PMID: 18612534
27. Donze J, Rodondi N, Waeber G, Monney P, Cornuz J, Aujesky D (2012) Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study. Am J Med 125: 1095-1102. S0002-9343(12)00287-2 [pii];doi: 10.1016/j.amjmed.2012.04.005 PMID: 22939362
28. Seet RC, Rabinstein AA, Christianson TJ, Petty GW, Brown RD Jr. (2013) Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. J Stroke Cerebrovasc Dis 22: 561-569. S1052-3057(13)00025-6 [pii];doi: 10.1016/j.jstrokecerebrovasdis.2013.01.019 PMID: 23499334
29. Gallego P, Roldan V, Torregrosa JM, Galvez J, Valdes M, Vicente V, et al (2012) Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol 5: 312-318. CIRCEP.111.967000 [pii];doi: 10.1161/CIRCEP.111.967000 PMID: 22319005
30. Lip GY, Frison L, Halperin JL, Lane DA (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 57: 173-180. S0735-1097(10)04337-8 [pii];doi: 10.1016/j.jacc.2010.09.024 PMID: 21111555
31. Lip GY, Lin HJ, Hsu HC, Su TC, Chen MF, Lee YT, et al (2013) Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study. Int J Cardiol. S0167-5273(12)01705-6 [pii];doi: 10.1016/j.ijcard.2012.12.076
32. Smith JG, Wieloch M, Koul S, Braun OO, Lumsden J, Rydell E, et al (2012) Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score. EuroIntervention 8: 672-678. EIJV8I6A105 [pii];doi: 10.4244/EIJV8I6A105 PMID: 23086784
33. Omran H, Bauersachs R, Rubenacker S, Goss F, Hammerstingl C (2012) The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 108: 65-73. 11-12-0827 [pii];doi: 10.1160/TH11-12-0827 PMID: 22534746
34. Poli D, Antonucci E, Testa S, Cosmi B, Palareti G, Ageno W (2013) The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study. J Thromb Haemost 11: 1053-1058. doi: 10.1111/jth.12239 PMID: 23578305
35. Burgess S, Crown N, Louzada ML, Dresser G, Kim RB, Lazo-Langner A (2013) Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin. J Thromb Haemost 11: 1647-1654. doi: 10.1111/jth.12352 PMID: 23848301
36. Wong PY, Schulman S, Woodworth S, Holbrook A (2013) Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis. J Thromb Haemost 11: 491-502. doi: 10.1111/jth.12107 PMID: 23279062
37. Beyth RJ, Quinn L, Landefeld CS (2000) A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med 133: 687-695. 200011070-00010 [pii]. PMID: 11074901
38. Wells PS, Forgie MA, Simms M, Greene A, Touchie D, Lewis G, et al (2003) The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Arch Intern Med 163: 917-920. doi: 10.1001/archinte.163.8.917;163/8/917 [pii]. PMID: 12719200